People · Operator
Named in public records as an officer, director or promoter · active 2011–2014 · Manufacturing, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| BioCision, LLC | — | Manufacturing | Series A | $11.3M | $27.5M | 2012 |
| Biotix Holdings Inc. | — | Biotechnology | Seed | $4.2M | $97.5M | 2011 |
Paul J. Nowak at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Paul J. Nowak on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Charles P. Cullen | 1 | 2 |
| Hugh J. Douglas | 1 | 1 |
| Ron W. DiNocco | 1 | 1 |
| Brian J. Schryver | 1 | 1 |
| Rolf O. Ehrhardt | 1 | 1 |
| Brian E. Schryver | 1 | 1 |
| Paul E. Nowak | 1 | 1 |
| Hugh E. Douglas | 1 | 1 |
| Ryan A. Kirkpatrick | 1 | 1 |
| Anthony J. Altig | 1 | 1 |
| Lawson P. DeVries | 1 | 1 |
| Blair W. Stewart | 1 | 1 |
| David A. Freeman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.